Simplified Chinese version of the international prostate symptom score and the benign prostatic hyperplasia impact index: cross-cultural adaptation, reliability, and validity for patients with benign prostatic hyperplasia
Background: The aim of this study was to translate and cross-culturally adapt the international prostate symptom score (IPSS) and benign prostatic hyperplasia impact index (BII) into simplified Chinese for mainland Chinese patients with benign prostatic hyperplasia (BPH). Methods: The original Engli...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-09-01
|
Series: | Prostate International |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2287888222000186 |
_version_ | 1797709901340868608 |
---|---|
author | Rong-liang Dun Jian-min Mao Chao Yu Qiang Zhang Xiao-hua Hu Wen-jing Zhu Guang-chong Qi Yu Peng |
author_facet | Rong-liang Dun Jian-min Mao Chao Yu Qiang Zhang Xiao-hua Hu Wen-jing Zhu Guang-chong Qi Yu Peng |
author_sort | Rong-liang Dun |
collection | DOAJ |
description | Background: The aim of this study was to translate and cross-culturally adapt the international prostate symptom score (IPSS) and benign prostatic hyperplasia impact index (BII) into simplified Chinese for mainland Chinese patients with benign prostatic hyperplasia (BPH). Methods: The original English IPSS and BII were translated into simplified Chinese versions based on cross-cultural adaptation guidelines. Internal consistency was evaluated with Cronbach’s α, then test-retest reliability with intraclass correlation coefficients (ICCs) in stable patients. The validity of these two adaptations was tested by the correlation between the IPSS and BII with visual prostate symptom score (VPSS) and 36 items Short Form Health Survey (SF-36). The floor and ceiling effects were calculated by the proportion of participants who obtained the highest and lowest possible score. Results: A total of 105 native Chinese-speaking patients with BPH were enrolled. Cronbach’s α was over 0.75 for the simplified Chinese IPSS (IPSS 0.815; IPSS-symptom 0.782) and 0.709 for the simplified Chinese BII, indicating acceptable internal consistency. The ICCs for the test-retest reliability were over 0.75 (IPSS, r = 0.836; IPSS-symptom, r = 0.801; IPSS-quality of life, r = 0.794; BII, r = 0.758), indicating excellent test-retest reliability. There were very good positive correlations between IPSS and BII (r = 0.605), as well as VPSS (r = 0.634), and very good or good negative correlations between IPSS-Qol and SF-36 physical functioning (r = −0.621), and vitality (r = −0.659), and between BII and SF-36 physical functioning (r = −0.421). No floor or ceiling effect was detected in the simplified Chinese IPSS and BII. Conclusions: This study indicates that the simplified Chinese IPSS and BII are reliable and valid measurements of the symptom and quality of life among Chinese patients with BPH, which is likely to be widely used in this population. |
first_indexed | 2024-03-12T06:44:32Z |
format | Article |
id | doaj.art-ce59ebc5da384296ac7d86020ca5e4c8 |
institution | Directory Open Access Journal |
issn | 2287-8882 |
language | English |
last_indexed | 2024-03-12T06:44:32Z |
publishDate | 2022-09-01 |
publisher | Elsevier |
record_format | Article |
series | Prostate International |
spelling | doaj.art-ce59ebc5da384296ac7d86020ca5e4c82023-09-03T00:46:24ZengElsevierProstate International2287-88822022-09-01103162168Simplified Chinese version of the international prostate symptom score and the benign prostatic hyperplasia impact index: cross-cultural adaptation, reliability, and validity for patients with benign prostatic hyperplasiaRong-liang Dun0Jian-min Mao1Chao Yu2Qiang Zhang3Xiao-hua Hu4Wen-jing Zhu5Guang-chong Qi6Yu Peng7Urology Surgery, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, ChinaAndrology, Shanghai Seventh People’s Hospital, Shanghai, ChinaUrology Surgery, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, ChinaUrology Surgery, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, ChinaUrology Surgery, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, ChinaUrology Surgery, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, ChinaUrology Surgery, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, ChinaUrology Surgery, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China; Corresponding author. Yueyang Hospital of Integrated Traditional Chinese and Western Medicine Hospital, 110 Ganhe Road, Shanghai 200437, China.Background: The aim of this study was to translate and cross-culturally adapt the international prostate symptom score (IPSS) and benign prostatic hyperplasia impact index (BII) into simplified Chinese for mainland Chinese patients with benign prostatic hyperplasia (BPH). Methods: The original English IPSS and BII were translated into simplified Chinese versions based on cross-cultural adaptation guidelines. Internal consistency was evaluated with Cronbach’s α, then test-retest reliability with intraclass correlation coefficients (ICCs) in stable patients. The validity of these two adaptations was tested by the correlation between the IPSS and BII with visual prostate symptom score (VPSS) and 36 items Short Form Health Survey (SF-36). The floor and ceiling effects were calculated by the proportion of participants who obtained the highest and lowest possible score. Results: A total of 105 native Chinese-speaking patients with BPH were enrolled. Cronbach’s α was over 0.75 for the simplified Chinese IPSS (IPSS 0.815; IPSS-symptom 0.782) and 0.709 for the simplified Chinese BII, indicating acceptable internal consistency. The ICCs for the test-retest reliability were over 0.75 (IPSS, r = 0.836; IPSS-symptom, r = 0.801; IPSS-quality of life, r = 0.794; BII, r = 0.758), indicating excellent test-retest reliability. There were very good positive correlations between IPSS and BII (r = 0.605), as well as VPSS (r = 0.634), and very good or good negative correlations between IPSS-Qol and SF-36 physical functioning (r = −0.621), and vitality (r = −0.659), and between BII and SF-36 physical functioning (r = −0.421). No floor or ceiling effect was detected in the simplified Chinese IPSS and BII. Conclusions: This study indicates that the simplified Chinese IPSS and BII are reliable and valid measurements of the symptom and quality of life among Chinese patients with BPH, which is likely to be widely used in this population.http://www.sciencedirect.com/science/article/pii/S2287888222000186Benign prostatic hyperplasiaCross-cultural adaptationPsychometricQuality of lifeQuestionnaires |
spellingShingle | Rong-liang Dun Jian-min Mao Chao Yu Qiang Zhang Xiao-hua Hu Wen-jing Zhu Guang-chong Qi Yu Peng Simplified Chinese version of the international prostate symptom score and the benign prostatic hyperplasia impact index: cross-cultural adaptation, reliability, and validity for patients with benign prostatic hyperplasia Prostate International Benign prostatic hyperplasia Cross-cultural adaptation Psychometric Quality of life Questionnaires |
title | Simplified Chinese version of the international prostate symptom score and the benign prostatic hyperplasia impact index: cross-cultural adaptation, reliability, and validity for patients with benign prostatic hyperplasia |
title_full | Simplified Chinese version of the international prostate symptom score and the benign prostatic hyperplasia impact index: cross-cultural adaptation, reliability, and validity for patients with benign prostatic hyperplasia |
title_fullStr | Simplified Chinese version of the international prostate symptom score and the benign prostatic hyperplasia impact index: cross-cultural adaptation, reliability, and validity for patients with benign prostatic hyperplasia |
title_full_unstemmed | Simplified Chinese version of the international prostate symptom score and the benign prostatic hyperplasia impact index: cross-cultural adaptation, reliability, and validity for patients with benign prostatic hyperplasia |
title_short | Simplified Chinese version of the international prostate symptom score and the benign prostatic hyperplasia impact index: cross-cultural adaptation, reliability, and validity for patients with benign prostatic hyperplasia |
title_sort | simplified chinese version of the international prostate symptom score and the benign prostatic hyperplasia impact index cross cultural adaptation reliability and validity for patients with benign prostatic hyperplasia |
topic | Benign prostatic hyperplasia Cross-cultural adaptation Psychometric Quality of life Questionnaires |
url | http://www.sciencedirect.com/science/article/pii/S2287888222000186 |
work_keys_str_mv | AT rongliangdun simplifiedchineseversionoftheinternationalprostatesymptomscoreandthebenignprostatichyperplasiaimpactindexcrossculturaladaptationreliabilityandvalidityforpatientswithbenignprostatichyperplasia AT jianminmao simplifiedchineseversionoftheinternationalprostatesymptomscoreandthebenignprostatichyperplasiaimpactindexcrossculturaladaptationreliabilityandvalidityforpatientswithbenignprostatichyperplasia AT chaoyu simplifiedchineseversionoftheinternationalprostatesymptomscoreandthebenignprostatichyperplasiaimpactindexcrossculturaladaptationreliabilityandvalidityforpatientswithbenignprostatichyperplasia AT qiangzhang simplifiedchineseversionoftheinternationalprostatesymptomscoreandthebenignprostatichyperplasiaimpactindexcrossculturaladaptationreliabilityandvalidityforpatientswithbenignprostatichyperplasia AT xiaohuahu simplifiedchineseversionoftheinternationalprostatesymptomscoreandthebenignprostatichyperplasiaimpactindexcrossculturaladaptationreliabilityandvalidityforpatientswithbenignprostatichyperplasia AT wenjingzhu simplifiedchineseversionoftheinternationalprostatesymptomscoreandthebenignprostatichyperplasiaimpactindexcrossculturaladaptationreliabilityandvalidityforpatientswithbenignprostatichyperplasia AT guangchongqi simplifiedchineseversionoftheinternationalprostatesymptomscoreandthebenignprostatichyperplasiaimpactindexcrossculturaladaptationreliabilityandvalidityforpatientswithbenignprostatichyperplasia AT yupeng simplifiedchineseversionoftheinternationalprostatesymptomscoreandthebenignprostatichyperplasiaimpactindexcrossculturaladaptationreliabilityandvalidityforpatientswithbenignprostatichyperplasia |